Mnemo Therapeutics
Developing immune-based therapies
- B2B
About Mnemo Therapeutics
Biotechnology company developing immune-based therapies for solid tumors and blood cancers using EnfiniT platform for improved T cell response
Key facts
- Industry
- Biotechnology Research
- Company size
- 11–50 employees
- Headquarters
- Paris, Île-de-France, France
- Founded
- 2019
- Revenue
- $4.3M – $33.8MTamtam estimate
- Website
- mnemo-tx.com
Mnemo Therapeutics at a glance
Mnemo Therapeutics is a B2B company in the Biotechnology Research industry, headquartered in Paris, Île-de-France, France.
Mnemo Therapeutics was founded in 2019.
Mnemo Therapeutics has 11–50 employees.
Mnemo Therapeutics's revenue is $4.3M – $33.8M (Tamtam estimate).
Selling to companies like Mnemo Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies